Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
IDH1 mutation
Cancer:
Astrocytoma
Regimen:
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
NCCN
Excerpt:
ADULT GLIOMA: IDH-MUTANT ASTROCYTOMA...Adjuvant Treatment WHO grade 2, KPS ≥60….Preferred Regimens...RT + adjuvant PCV (category 1)...Other Recommended Regimens...PCV
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.